Macquarie Group LTD Eagle Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$3.34 - $5.6 $1,730 - $2,900	518 New	518 $2,000
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $11,968 - $21,345	-453 Closed	0 $12,000
Q1 2021 May 14, 2021	SELL	$40.32 - $50.97 $8,668 - $10,958	-215 Reduced 32.19%	453 $19,000
Q2 2020 Aug 11, 2020	SELL	$43.24 - $55.02 $87,863 - $111,800	-2,032 Reduced 75.26%	668 $32,000
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $122,475 - $137,954	-2,300 Reduced 46.0%	2,700 $153,000
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $233,050 - $292,250	5,000 New	5,000 $278,000
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $3,865 - $5,182	-100 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$36.72 - $67.73 $7,344 - $13,546	-200 Reduced 66.67%	100 $4,000
Q3 2018 Nov 15, 2018	SELL	$66.65 - $83.86 $79,980 - $100,632	-1,200 Reduced 80.0%	300 $21,000
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $61,500 - $91,944	1,200 Added 400.0%	1,500 $113,000
Q1 2018 May 11, 2018	SELL	$52.16 - $66.86 $161,696 - $207,266	-3,100 Reduced 91.18%	300 $16,000
Q4 2017 Feb 15, 2018	SELL	$49.6 - $60.87 $94,240 - $115,653	-1,900 Reduced 35.85%	3,400 $182,000
Q3 2017 Nov 08, 2017	BUY	$46.62 - $60.36 $247,086 - $319,908	5,300	5,300 $316,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.